Prospective Randomized Comparison of Imipenem-Cilastatin and Piperacillin-Tazobactam in Nosocomial Pneumonia or Peritonitis

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.3.726
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Prospective Randomized Controlled Study of Ciprofloxacin Versus Imipenem-Cilastatin in Severe Clinical Infections.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Cost-Effectiveness Analysis of Tigecycline in Comparision With Imipenem/Cilastatin or Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections: A Perspective of Iranian Health Systems

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Economic Evaluation of Imipenem-Cilastatin Versus Doripenem in Ventilatorassociated Pneumonia in Egypt

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Erratum To: Imipenem/Cilastatin

Drugs
Pharmacology
1992English

Effect of Applying the New Clinical and Laboratory Standards Institute Ticarcillin/Clavulanic Acid, Piperacillin, Piperacillin/Tazobactam and Imipenem Susceptibility Breakpoints for Pseudomonas Aeruginosa in Hong Kong

International Journal of Antimicrobial Agents
MedicineInfectious DiseasesMicrobiologyPharmacology
2012English

Nephrotoxicity Induced by Piperacillin–Tazobactam in Late Elderly Japanese Patients With Nursing and Healthcare Associated Pneumonia

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2014English

Biliary Excretion of Imipenem-Cilastatin in Hospitalized Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Randomized Phase 2 Trial to Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens Versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients With Pneumonia

Antibiotics
PharmacologyBiochemistryMicrobiologyToxicologyInfectious DiseasesPharmaceutics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy